3266F Hepatitis C genotype testing documented as performed prior to initiation of antiviral treatment for Hepatitis C (HEP C)

Name of the Procedure:

Hepatitis C Genotype Testing

Summary

Hepatitis C genotype testing is a medical test used to determine the specific genetic strain of the Hepatitis C virus (HCV) in a patient's blood. This information helps guide the selection of the most effective antiviral treatment.

Purpose

The test addresses chronic Hepatitis C infection and aims to tailor antiviral therapy to the specific virus genotype. Identifying the genotype is essential for optimizing treatment strategy, increasing the likelihood of a successful outcome, and reducing the duration and side effects of therapy.

Indications

• Chronic Hepatitis C infection confirmed through prior testing.
• Prior to initiating antiviral treatment to customize therapy.
• Patients presenting with symptoms of Hepatitis C, such as jaundice, fatigue, and abnormal liver enzyme levels.

Preparation

• No special preparation is typically required.
• Patients may be advised to disclose their medical history and any medications they are currently taking.
• Basic blood tests may be performed beforehand to assess liver function.

Procedure Description

1. Blood Sample Collection: A healthcare professional draws a blood sample from the patient's vein, usually from the arm.
2. Laboratory Analysis: The blood sample is sent to a laboratory where HCV RNA is extracted and its genotype is determined using molecular techniques such as polymerase chain reaction (PCR).
3. Result Interpretation: The test results, which identify the specific HCV genotype, are reported to the healthcare provider responsible for treatment planning.

Duration

The blood sample collection takes a few minutes, but it may take several days to a week for the laboratory analysis and results.

Setting

• Outpatient clinic or hospital laboratory

Personnel

• Phlebotomist or nurse for blood sample collection
• Laboratory technician or molecular biologist for analysis
• Consulting physician for treatment planning

Risks and Complications

• Minor discomfort or bruising at the blood draw site
• Rare risk of infection at the puncture site

Benefits

• Provides critical information for selecting the most effective antiviral regimen.
• Enhances the chances of achieving a sustained virological response (SVR), leading to potential cure.
• Helps in minimizing treatment side effects and duration.

Recovery

• No recovery time is required post blood draw.
• The patient can resume normal activities immediately.

Alternatives

• The primary alternative is to start treatment without genotype testing; however, this is not recommended as it may lead to suboptimal treatment outcomes.
• Other diagnostic tests may be used to complement genotype testing, such as liver function tests and HCV RNA quantification.

Patient Experience

• The patient may feel a brief sting or pinch during the blood draw.
• Some patients might experience minor bruising or discomfort at the puncture site, which usually resolves quickly.
• The process is typically quick and straightforward, with minimal pain and inconvenience.